NCT07120100View on ClinicalTrials.gov

Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 27, 2025

Primary Completion Date

September 15, 2027

Study Completion Date

September 15, 2028

Conditions

Breast Cancer FemaleGynecologic Cancer

Interventions

DEVICE

rTMS

Repetitive Transcranial Magnetic Stimulation will be administered Monday-Friday for two weeks (10 sessions total)

Trial Locations (1)

84112

RECRUITING

Huntsman Cancer Institute at University of Utah, Salt Lake City

All Listed Sponsors

lead

University of Utah

OTHER

NCT07120100 - Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors | Biotech Hunter | Biotech Hunter